Berthiaume Institute for Precision Health · Technology Bridge Fund We’re delighted to announce that the pdnano lab has received a Berthiaume Institute for Precision Health (BIPH) Technology Bridge Fund award. The Technology Bridge program supports promising precision-health projects in generating the additional preliminary data needed to strengthen high-impact grant resubmissions. The funded project — Multispecific …
Category Archive: metastatic cancer cells
Apr 24
Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event
Harper Cancer Research Institute, Hybrid nanoparticles, IDEA center, metastatic cancer cells, multidrug resistance
by Prakash
On Friday, April 24, 2026, I had the privilege of being one of six Notre Dame faculty selected to pitch at the inaugural Research Commercialization Grant (RCG) Pitch Event, hosted by the IDEA Center at Notre Dame in Leighton Hall at Innovation Park. The morning brought together external investors, the IDEA Center Advisory Council, and …
Apr 03
Society for Biomaterials – Seattle 2019
AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Conference abstracts, metastatic cancer cells, multidrug resistance, SFB2019
by Prakash
I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …
Tags: #AD&T, #americancancersociety, #CTSI, NDNano
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Tags: NDNano
Aug 30
Nanoparticles that act as an “ON and OFF” switch to improve the safety and effectiveness of CAR-T cancer therapy
AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Harper Cancer Research Institute, Immunotherapy, metastatic cancer cells
by Prakash
Always thankful for the internal support from Notre Dame Research #notredameresearch for supporting high risk-high gain projects such as mine. Here’s hoping that my faculty research support program initiation grant (FRSP-IG) #FRSP will pave the way for safer, more accessible CAR-T therapies and better quality of life for patients. https://research.nd.edu/news/developing-an-on-and-off-switch-for-breast-cancer-treatment/ The biggest bottle neck in Chimeric …
Tags: NDNano
Jul 02
Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters
AD&T Notre Dame, Berthiaume Institute for Precision Health, Cancer stem cells, Combination chemotherapy, Harper Cancer Research Institute, metastatic cancer cells
by Prakash
Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/
Tags: NDNano
Recent Posts
- pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine June 19, 2026
- AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter May 9, 2026
- Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms May 9, 2026
- Lab Family Dinner 2026: Celebrating Our Team and Sending Off Our Graduating Seniors April 28, 2026
- Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event April 24, 2026
Archives
Categories
NIH Funding Opportunities
- Notice of Information: Implementation of HHS Annual SBIR and STTR Application/Proposal Limit July 10, 2026Notice NOT-OD-26-090 from the NIH Guide for Grants and Contracts
- Inviting Comments and Suggestions on Topic Areas for the NIDCR Strategic Plan for Fiscal Years 2027-2031 July 8, 2026Notice NOT-DE-26-015 from the NIH Guide for Grants and Contracts
- Notice of Change: Early Expiration of Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) July 8, 2026Notice NOT-NS-26-040 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-24-252 "Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)" July 7, 2026Notice NOT-GM-26-010 from the NIH Guide for Grants and Contracts



Recent Comments